RALEIGH, N.C., April 8 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, a PRA Health Sciences company, will make a 30-day license of its newly released MetysTM COVID-19 Module available to the U.S. life science industry at no charge. The COVID-19 Module within the Metys platform will provide up to three [...]
RALEIGH, N.C., March 11 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today a partnership between Symphony Health and Datavant that expands the breadth of data available for integration and allows life sciences companies to get the deepest and most holistic view of the patient journey in the commercial market. Symphony Health’s proprietary Synoma® de-identification [...]
RALEIGH, N.C., Sept. 18 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today the launch of Symphony Health’s new national market measurement tool – Metys™ (pronounced Met-IS), the only completely integrated, all-in-one market research solution available from a contract research organization (CRO). The first platform of its kind, Metys delivers pharmaceutical market analytics and intelligence [...]
RALEIGH, N.C., Aug. 19 (Korea Bizwire) — PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, the company’s data solutions division, has expanded its global data services by entering into a strategic partnership with Close-Up International, a leading Latin American-based provider of medical prescription and sales audits. “The agreement with Close-Up represents a significant milestone [...]